Skip to main content

Advertisement

Table 2 Plasma clinical chemistries

From: Different doses of supplemental vitamin D maintain interleukin-5 without altering skeletal muscle strength: a randomized, double-blind, placebo-controlled study in vitamin D sufficient adults

  placebo 200 IU 4000 IU
PTH (pg/ml)    
   Pre 36.1 (13.9) 36.1 (14.6) 31.4 (10.3)
   7-d 40.7 (16.5) 35.8 (16.4) 30.8 (11.4)
   14-d 38.5 (11.0) 31.7 (13.1) 30.3 (7.9)
   21-d 35.0 (13.5) 31.1 (11.0) 25.9 (8.3)
   28-d 35.5 (12.6) 33.0 (17.9) 32.1 (11.4)
calcium (mg/dl)    
   Pre 9.22 (0.27) 9.36 (0.26) 9.32 (0.22)
   7-d 9.06 (0.16) 9.21 (0.38) 9.38 (0.26)
   14-d 9.15 (0.24) 9.22 (0.27) 9.41 (0.21)
   21-d 9.09 (0.31) 9.38 (0.29) 9.30 (0.28)
   28-d 9.16 (0.24) 9.39 (0.35) 9.35 (0.23)
creatinine (mg/dl)    
   Pre 0.93 (0.08) 0.91 (0.14) 0.98 (0.17)
   7-d 0.92 (0.08) 0.97 (0.16) 0.98 (0.15)
   14-d 0.94 (0.09) 0.92 (0.13) 0.97 (0.17)
   21-d 0.92 (0.13) 0.92 (0.15) 0.98 (0.15)
   28-d 0.94 (0.16) 0.91 (0.15) 1.01 (0.13)
eGFR (ml/min/1.73 m2)    
   Pre 90.9 (15.6) 91.9 (12.6) 87.7 (11.3)
   7-d 91.1 (12.3) 85.5 (15.0) 87.5 (10.2)
   14-d 89.1 (13.0) 89.7 (9.2) 89.5 (12.5)
   21-d 91.6 (8.0) 91.0 (13.2) 88.0 (12.5)
   28-d 90.2 (12.1) 92.1 (14.3) 84.7 (9.3)
  1. Data presented as mean (SD)